Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 47Observational 2

Sponsor

Cancer Type

CNS 3Dermatologic 2Endocrine 1

Conditions

Non-Melanoma Skin Cancer (NMSC) 1Keratosis, Actinic 1

Interventions

Blood Specimen Collection 22Surveys and Questionnaires 19Nivolumab 14Ipilimumab 12pembrolizumab 11Gene Expression Profiling 11Biopsy 10trametinib 9dabrafenib 8Flow Cytometry 8Specimen Handling 7Polymerase Chain Reaction 7Tomography, Optical Coherence 6Therapeutics 6Immunohistochemistry 6Imiquimod 6Amplified Fragment Length Polymorphism Analysis 6Watchful Waiting 5Psychiatric Rehabilitation 5Immunotherapy 5Data Collection 53-ingenyl angelate 5Mohs Surgery 4Microarray Analysis 4Interviews as Topic 4Immunoenzyme Techniques 4Drug Therapy 4Dermoscopy 4sonidegib 3encorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Aminolevulinic Acid × Dermatologic × Clear all
NCT07201376 2026-02-06

PPIX

Dartmouth-Hitchcock Medical Center

Recruiting
125 enrolled
Dermatologic

Non-Melanoma Skin Cancer (NMSC)

NCT02209012 2016-09-23

Twelve Month Follow-Up of CP0108

DUSA Pharmaceuticals, Inc.

Completed
206 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡